To investigate the effect of MEG3 on cisplatin resistance in cervical cancer cells, we established Hela-CR, which IC50 values were significantly higher (Fig. 1B) and the MEG3 levels were significantly lower than Hela cells (Fig. 1C). The gene discussed is MEG3; the disease is cervical cancer.